Atlas Trials

Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer

Clinical trial NCT00575952 · COMPLETED

Trial details

NCT number
NCT00575952
Sponsor
Gynecologic Oncology Group
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Endometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed AdenocarcinomaEndometrial Serous AdenocarcinomaEndometrial Squamous Cell CarcinomaEndometrial Undifferentiated CarcinomaRecurrent Uterine Corpus CarcinomaStage IIIA Uterine Corpus CancerStage IIIC Uterine Corpus CancerStage IVA Uterine Corpus CancerStage IVB Uterine Corpus Cancer
Start date
2008-01-17
Primary completion
2016-07-16
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.